Personalised Medicine Patents at the EPO
In this article, Associate Dr Liam Lawlor reviews how the EPO considers medical use claims, before looking more closely at patenting personalised medicines at the EPO.
Ideas lead to innovation and innovation distinguishes those companies that lead from those that follow
TLIP Ltd – leading European Patent & Trade Mark Attorneys and Portfolio Management Support
Our clients’ commercial interests extend across the world. To support those interests, TLIP has appointed a network of approved overseas associate firms with expert local knowledge. We work together to provide you with a truly international service.
Stop Press: Decison today on Claims to Plants Produced by Essentially Biological Processes
The Enlarged Board of Appeal of the European Patent Office issued opinion G 3/19 (Pepper) today 14 May 2020 and concluded that plants and animals exclusively obtained by essentially biological processes are not patentable.
MAY UPDATE: Coronavirus pandemic advice from patent offices
The UK IPO and EPO remain “open for business” during the coronavirus outbreak with some deadlines extended.
Proceedings at EPO via Videoconference
Video conferencing rather than a visit to Munich or the Hague is now the default for examining division oral proceedings. Lisa Brown discusses the recent change of policy at the EPO.
TLIP attorneys work in specialist technology and legal fields. Our attorneys include an astrophysicist, a synthetic chemist, an IBM patent engineer, an electronic engineer, a mechanical engineer and a toxicologist. Whilst we are mostly known for our original patent drafting and patent prosecution, we also advise our clients across all IP rights: including trade secrets, contracts and licensing. We combine this with a good dose of real life experience and learning from clients that continually push the boundaries of what is possible.